Test Price
450 AED✅ Home Collection Available
CD3 Immunohistochemistry Test in UAE | 450 AED | DHA-Licensed Oncopathology
Executive Summary & Core Metrics
The CD3 Immunohistochemistry (IHC) assay delivers semi-quantitative detection of CD3 surface antigen on T‑lymphocytes within formalin‑fixed paraffin‑embedded (FFPE) tumor tissue, enabling precise classification of lymphomas and guiding targeted immunotherapy protocols. This DHA‑recognized test is processed under ISO 9001:2015 accredited workflows (Cert: INT/EGQ/2509DA/3139).
- Diagnostic Accuracy: 99.9% sensitivity via standardized IHC with DAB detection and hematoxylin counterstain.
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval — archival FFPE blocks or biopsy slides collected via certified courier from any UAE healthcare facility.
- Clinical Oversight: Post-result telephonic interpretation by a DHA‑licensed specialist diagnostic radiologist.
- Insurance Verification: Direct billing confirmation via WhatsApp at +971 54 548 8731 — forward your policy card for immediate pre‑approval.
Test Overview & Methodology
The CD3 IHC test identifies CD3‑positive T‑cell lymphocytes within the native tissue architecture of FFPE biopsies. By using a monoclonal anti‑CD3 antibody, chromogenic detection (DAB), and hematoxylin counterstain, pathologists can distinguish reactive T‑cell infiltrates from malignant T‑cell lymphoproliferative disorders. The assay is performed on automated IHC platforms following CAP/CLSI guidelines and is correlated with morphological evaluation and ancillary molecular markers.
| Feature | Our Test (CD3 IHC) | Closest Alternative (Flow Cytometry) |
|---|---|---|
| Precision | Semi‑quantitative in situ localization within preserved tissue architecture | Suspension‑based analysis; morphological context may be lost |
| Methodology | IHC with DAB detection and hematoxylin counterstain (DHA‑approved protocol) | Multiparametric flow with fluorochrome‑conjugated antibodies; requires fresh tissue |
| Speed | 5–7 days (large or complex biopsies may require up to 7 days) | 2–3 days but requires fresh unfixed tissue within 24 hours of collection |
Physician Insight & Safety Protocols
“As a DHA‑licensed specialist in diagnostic radiology, I underscore that the CD3 IHC result must be interpreted in concert with clinical history, imaging findings, and complementary laboratory markers. A positive CD3 signal alone does not confirm malignancy; correlation with morphology, co‑expressed markers, and the full clinical picture is essential to avert diagnostic error. Our telephonic post‑test consultation is available to support clinicians in synthesizing these data for informed therapeutic decisions.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication Advisory
Medication Advisory
Do not discontinue any prescribed medication — including immunosuppressants, anticoagulants, or corticosteroids — without explicit direction from your treating physician. Abrupt cessation may lead to serious adverse outcomes.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a tissue specimen (fresh biopsy or archival FFPE block). Active uncontrolled bleeding disorder or skin infection at the proposed biopsy site.
- Red Flag: Unexplained weight loss exceeding 10% within 3 months, persistent fever above 38.5 °C lasting more than 2 weeks, or rapidly enlarging lymph node. Contact your doctor immediately or visit the nearest emergency department if any of these signs develop.
- Red Flag: Severe pain, swelling, or purulent discharge at the biopsy site — suspect hematoma or infection; seek urgent medical evaluation.
Patient FAQ & Clinical Guidance
1. What is the CD3 immunohistochemistry test used for?
The CD3 IHC test identifies T‑cell lymphocytes within tumor tissue, aiding precise lymphoma diagnosis and personalized immunotherapy planning. It highlights CD3‑positive cells directly within the biopsy architecture, helping pathologists differentiate reactive from malignant T‑cell proliferations and guiding oncologists toward targeted treatment regimens.
2. How long do results take, and how is the sample collected?
Results are delivered within 5–7 days. The test requires an FFPE tissue block or unstained biopsy slides, which our medical courier retrieves directly from your hospital or clinic under secure chain‑of‑custody protocols. A copy of the histopathology report and relevant clinical history must accompany the specimen.
3. Is this test covered by insurance in the UAE?
Most UAE health insurance plans cover CD3 immunohistochemistry when deemed medically necessary. Verify your policy instantly by sending your insurance card via WhatsApp to +971 54 548 8731. Our team coordinates direct billing and pre‑approval with major insurers including Daman, AXA, and Oman Insurance.
4. What should I do if my results are abnormal or unclear?
If your CD3 IHC result is abnormal or equivocal, our DHA‑licensed specialist will provide a complimentary telephonic consultation to explain the findings in context. We recommend discussing all results with your referring physician, who may correlate them with imaging, blood counts, and additional biomarkers before finalizing a treatment plan.
UAE Regulatory & Data Privacy Adherence
All patient data and diagnostic records are handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | CD3 Immunohistochemistry (IHC) |
| Price (AED) | 450 AED |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | FFPE tissue block, unstained biopsy slides, or fresh tissue in formalin. Archival Tissue Specimen — Secure Medical Courier Solid Tissue Specimen Retrieval. |
| Methodology Used | Immunohistochemistry (IHC) with monoclonal anti‑CD3 antibody, DAB chromogenic detection, and hematoxylin counterstain; automated platform per CAP/CLSI guidelines. |
| ICD-10-CM Code | C84.40, C84.91, Z15.0 |
| LOINC Code | 44937-7 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians